Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Phase 1 Completed 59 enrolled AstraZeneca

RandomizedParallel-groupOpen-labelOther

This study will be a fixed sequence drug-drug interaction study in healthy postmenopausal females, conducted at multiple study sites

Evaluation	Drug	Modality	Dose	Route
Subject	Camizestrant	Other / unclassified	—	Oral
Subject	Celecoxib	Other / unclassified	—	Oral
Subject	Dabigatran etexilate	Unknown	—	Oral
Subject	Midazolam	Small molecule	—	Oral
Subject	Omeprazole	Other / unclassified	—	Oral

No indication recorded.